ArticleJournal of clinical medicine2020

Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer.

Chel Hun Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.